Wyss Institute's nasal swab and toehold switch technology are licensed to Agile Biodetection (IMAGE)
Caption
Harvard Wyss Institute's nasal swab (left) and toehold switch (right) technologies are licensed to Agile Biodetection, which will use them to develop solutions for unmet diagnostic needs in the detection of the SARS-CoV-2 virus in environmental and clinical settings.
Credit
Credit: Wyss Institute at Harvard University
Usage Restrictions
None
License
Licensed content